BPI21-006: Timing of NTRK Gene Fusion Testing and Treatment Modifications Following NTRK+ Status Among U.S. Oncologists Treating NTRK+ Patients

Authors: Landon Z. Marshall PharmD, PhD 1 , Andrew J. Klink PhD 1 , Abhishek Kavati PhD 2 , Ruth Antoine MBA 2 , Sibyl Anderson MD 2 and Bruce Feinberg MD 1
View More View Less
  • 1 Cardinal Health Specialty Solutions, Dublin, OH
  • 2 Bayer U.S. LLC, Whippany, NJ
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7757
Restricted access

All currencies in US Dollar

PayPal Logo

Corresponding Author: Landon Z. Marshall, PharmD, PhD
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
BPI21-006
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 131 131 45
PDF Downloads 155 155 27
EPUB Downloads 0 0 0